For the Quarter Ending March 2024
North America
The first quarter of 2024 has been challenging for Doxycycline Hydrochloride pricing in the North America region, with significant factors influencing market prices. In the USA, which has seen the maximum price changes, the pricing environment has been unstable. Prices have fluctuated throughout the quarter, with a decrease in January followed by an increase in February and a decrease again in March. These fluctuations can be attributed to various factors such as demand dynamics, inventory levels, and global trade activity.
At the start of the quarter, prices saw a slight drop because of reduced demand from downstream sectors and ample supply. This decreased demand was worsened by inflation and the Federal Reserve's decision to maintain steady rates. However, prices rose in the middle of the quarter as downstream industries demanded more, putting pressure on the already tight domestic supply. Also, disruptions in key maritime routes, like the Red Sea and Panama Canal, created challenges for shippers bringing Doxycycline Hydrochloride into the US, worsening supply issues. Nonetheless, prices took a significant hit again in March due to a downturn in business confidence, which has created uncertainty about the economy. This uncertainty has led to subdued demand from pharmaceutical and healthcare industries.
The quarter-ending price for Doxycycline Hydrochloride in the USA was recorded at USD 42060/MT (USP, FDA) CFR Houston. Factors such as decreased demand, surplus supply, economic uncertainties, and inflationary pressures have contributed to the fluctuating prices.
Asia Pacific
During the first quarter of 2024, the pricing landscape for Doxycycline Hydrochloride in the APAC region underwent significant shifts influenced by several factors. In China, the largest market for this product in the region, prices initially dropped due to decreased demand from downstream sectors, impacting the overall market negatively. China's manufacturing sector faced challenges characterized by a slow domestic recovery and subdued external demand. However, as the quarter progressed, prices gradually rose due to a resurgence in demand from end-user industries and improved market sentiments. Seasonal fluctuations also affected pricing, with increased demand during the winter season in India. Despite a rise in economic activity in China after an extended holiday period, prices declined again in March due to concerns about inadequate domestic demand, overshadowing the positive momentum. Overall, the pricing environment for Doxycycline Hydrochloride in the APAC region was volatile, with fluctuations driven by varying supply and demand dynamics across different markets. The quarter concluded with Doxycycline Hydrochloride priced at USD 40995 per metric ton in China.
Europe
In the first quarter of 2024, the pricing landscape for Doxycycline Hydrochloride in the European region presented challenges influenced by several significant factors. Initially, prices saw a slight decline, reflecting subdued consumer sentiments and economic concerns. This decrease stemmed from weakened demand in both the pharmaceutical and healthcare sectors. However, prices surged in the middle of the quarter due to various reasons, including increased consumer demand, logistical hurdles, and limited inventories in the domestic market. Shipping and logistical disruptions, typical during the Spring festival in China, led to delays and higher transportation costs, which were passed on to buyers, contributing to the upward trajectory of Doxycycline Hydrochloride prices. A significant driver of this increase was heightened consumer demand, particularly driven by changing weather conditions that increased the need for antibiotics like Doxycycline Hydrochloride. Nevertheless, prices saw a significant decline again in March due to persistently poor performance in new industrial orders, marked by insufficient domestic demand amid a relatively high backlog. As of the quarter's end, the price of Doxycycline Hydrochloride in Germany was recorded at USD 43645 per metric ton (USP, FDA) CFR Hamburg.
For the Quarter Ending December 2023
North America
The pricing of Doxycycline Hydrochloride in the North America region during the fourth quarter of 2023 was influenced by several key factors. The market experienced a decline in prices, with an overall decrease of 14% compared to the previous quarter. This can be attributed to a combination of factors, such as reduced demand from the pharmaceutical and healthcare industries, excess supply in the market, and the impact of high interest rates on consumer purchasing power.
Additionally, the slowdown in inflation and the decline in gasoline and energy prices further contributed to the downward trend in prices. In terms of specific country analysis, the United States witnessed significant price fluctuations during the quarter. The country experienced a decrease of 4% in prices between the first and second half of the quarter, indicating a decline in demand and market activity. The overall price percentage change compared to the same quarter in the previous year was -14%, demonstrating a notable decrease in prices over time. The persistent subdued demand and surplus supply led to a bearish market sentiment.
In conclusion, the pricing of Doxycycline Hydrochloride in the North America region, particularly in the United States, was influenced by factors such as reduced demand, excess supply, high interest rates, and declining inflation. The market experienced a decline in prices, with a significant decrease compared to the previous quarter. The quarter ended with the latest price of USD 45075/MT of Doxycycline Hydrochloride (USP, FDA) CFR Houston in the USA.
APAC
The current quarter (Q4) of 2023 for Doxycycline Hydrochloride in the APAC region has been characterized by various factors that have impacted the market and prices. Insufficient market demand both domestically and internationally, along with a contraction in the manufacturing sector, has contributed to this trend. Additionally, there has been intense market competition and an abundance of supply in the Chinese market, leading to lower quotations. China, being a major player in the market, has experienced a significant impact on prices. The Chinese manufacturing sector has contracted, resulting in a decrease in export sales and a decline in new orders. This, coupled with a surplus supply in the domestic market, has led to lower prices for Doxycycline Hydrochloride. In terms of price trends, the current quarter's price of Doxycycline Hydrochloride in China is USD 44035/MT (USP, FDA) FOB Shanghai. There has been a significant decrease in prices compared to the same quarter last year, with a decline of -38%. Additionally, there has been a decrease of -13% in prices compared to the previous quarter of 2023. There has also been a slight decline of -3% in prices between the first and second half of the quarter. Overall, the market for Doxycycline Hydrochloride in the APAC region has been impacted by weak demand, intense competition, and a surplus supply. As a result of these influential factors, there has been a notable decline in prices, predominantly witnessed in China.
Europe
The fourth quarter of 2023 was challenging for the Doxycycline Hydrochloride market in Europe. The top three factors that impacted the market and prices were the persistently high inflation, resulting in reduced consumer spending and weakened demand. Additionally, the European Central Bank's ongoing interest rate hikes further constrained purchasing power and contributed to the decline in prices. Germany, being the largest economy in Europe, experienced a decline in overall demand and a decrease in industrial output, leading to a drop in Doxycycline Hydrochloride prices. The market also witnessed an ample supply of Doxycycline Hydrochloride, which further contributed to the downward trend. In terms of price analysis, the current quarter's price of Doxycycline Hydrochloride in Germany was USD 46580/MT, which represents the quarter-ending price. The percentage change in price from the previous quarter was -10%, indicating a significant decline. However, when compared to the same quarter of the previous year, there was no change in price. Overall, the Doxycycline Hydrochloride market in Europe faced challenges due to high inflation, reduced demand, and interest rate hikes, resulting in lower prices. The market dynamics in Germany played a significant role in shaping the pricing trends for the quarter.
For the Quarter Ending September 2023
North America
The prices of Doxycycline Hydrochloride in the United States exhibited a diverse trajectory during the third quarter, reflecting complex market dynamics. Prices initially rose by 3.81 percent in July due to factors such as inventory replenishment, increased demand from end-user sectors, and fewer imports from important exporting nations such as China. Consumer prices increased by 3.2 percent in July, raising company costs and contributing to the increase in Doxycycline Hydrochloride prices. However, prices declined by 3.00% and 4.85% in August and September, respectively, due to a drop in new orders and market consumption. Consumer prices jumped 3.7 percent in August, mainly due to increasing gasoline prices. Inflationary pressures weighed on customer purchasing power, resulting in an abundant supply of Doxycycline Hydrochloride, which contributed to price reductions. Moreover, consumers continued to struggle with the challenges posed by persistent inflation and historically high-interest rates in September, which have fostered a climate of economic uncertainty and diminished consumer confidence. According to the U.S. Bureau of Labor Statistics, the consumer price index experienced a steady 3.7% increase compared to the previous year, maintaining the same rate observed in August.
Asia Pacific
The prices of Doxycycline Hydrochloride exhibited a diverse trend in the Chinese market during the third quarter. Prices increased 4.03 percent in July due to increased demand from domestic and international markets, as well as a scarcity of supply in the market. The manufacturing sector remained in the contraction zone but improved in July compared to the previous situation, indicating that industrial sector production efficiency increased marginally due to increased market demand. Increased inquiries from both domestic and international markets prompted businesses to raise their selling prices, contributing to the upward trend. However, prices declined by 3.16% and 5.04% in August and September, respectively, due to lower end-user demand and enough market supply. Manufacturing activity fell for the sixth straight month in August, while service sector activity slowed as consumers continued to limit their spending. Furthermore, rising interest rates in important export regions lowered Doxycycline Hydrochloride demand in the foreign market, worsening the declining trend. Chinese exporters find themselves grappling with diplomatic tensions and an international endeavor to reduce dependence on China, leading to a further decline in demand from overseas markets.
Europe
The pricing of Doxycycline Hydrochloride displayed a diverse trend during the third quarter in Germany. Prices increased 3.93 percent in July due to increased demand from end users combined with decreased inventories among merchants and suppliers. The inflation rate was 6.2 percent in July, in comparison to 6.4 percent in June, as measured by the year-on-year change in the consumer price index (CPI). The score suggested that inflation eased in July, putting consumer confidence on the positive side. However, prices declined by 2.88% and 4.92% in August and September, respectively, due to lower end-user demand and enough market supply. Businesses were gloomy about the future as a result of rising interest rates, persistently high inflation, and consumer uncertainty, all of which weighed on demand for products and services, causing prices to fall in Germany. Apart from that, the ECB (European Central Bank) elevated interest rates to 4 percent for the tenth consecutive meeting in September, which reduced market demand and kept Doxycycline hydrochloride prices on the lower side.
For the Quarter Ending June 2023
North America
Doxycycline hydrochloride price plunged 14.78% in June compared to April. Doxycycline hydrochloride prices fell in the US due to ample supply and low demand. Market momentum continued to decline due to the erratic relationship between supply and demand. Nevertheless, weak market activity and lower product bids led to price declines in the second quarter. China is the largest exporter of APIs to the United States. Due to the ease of trading activity, exports of doxycycline hydrochloride to the United States increased, resulting in increased supply in the US market that put downward pressure on prices. In addition, inflation slowed in the second quarter due to the Federal Reserve's rate hikes, which subsequently reduced demand for doxycycline hydrochloride in the US market, driving down prices. Additionally, the appreciation of the US dollar against the Chinese yuan in June made US imports cheaper and increased the availability of doxycycline hydrochloride, supporting the downtrend. Unfavorable market conditions persisted as weak end-user demand forced market traders and suppliers to cut prices to clear inventories.
Asia Pacific
Doxycycline hydrochloride prices fell 15.34 percent in June compared to April. Factors behind this downward trend include abundant supply and declining demand in domestic and overseas markets. The depreciation of the Chinese yuan against the US dollar suggested that the momentum of the Chinese economy remained weak, signaling a slowdown in the global economy and increasing pressure on external demand from consumer sectors. China's manufacturing PMI remained below 50 in the second quarter, with the National Bureau of Statistics (NBS) showing June's PMI of 49, compared with 48.8 in May and 49.2 in April, suggesting a contraction in the manufacturing sector. This slowed production due to weak consumer demand from the medical and pharmaceutical sectors, resulting in lower purchasing activity, fewer new orders, and decreased prices for doxycycline hydrochloride. Meanwhile, the Ukraine war continued to affect API supply chains, hampering export activity to other countries, such as the United States, leading to increased supplies in the Chinese market and lower prices for doxycycline hydrochloride.
Europe
Doxycycline hydrochloride prices fell 15.43 percent in June from the levels noticed in April. Factors such as low purchasing activity and ample inventories in the German market contributed to this decline. In Germany, the manufacturing PMI (Purchasing Managers Index) for June 2023 fell to 41 from 43.2 in May and 44.5 in April, indicating a slump in the manufacturing sector due to the impact of the COVID-19 pandemic. Follow-up queries for new orders had decreased at a faster pace due to weakened demand from end consumers. Germany's economy was hit by rising inflation and higher European Central Bank interest rates, leading to higher food and energy prices. This increased the cost of living, reduced consumer purchasing activity, and supported the downward trend in the price of doxycycline hydrochloride. The euro's appreciation against the US dollar has made imports cheaper and increased the supply of doxycycline hydrochloride in the German market. This put downward pressure on the price of doxycycline hydrochloride.
For the Quarter Ending March 2023
North America
In the first quarter, the prices of Doxycycline Hydrochloride witnessed a mixed market trend in the North American region. With the start of the first quarter, the prices inclined considerably due to an increase in orders from domestic buyers. Also, traders faced the situation of costliest import from China as the Chinese currency gained against the US dollar, appreciating nearly 3% in January alone. Moreover, as February reached, the prices went down even after reasonable imports quotation from China and were recorded at USD 67455/MT CFR Houston. Towards the termination of Q1, demand for Doxycycline Hydrochloride increased again, keeping the prices in the northward direction.
APAC
Throughout the APAC region, particularly in China, the prices of Doxycycline Hydrochloride demonstrate a mixed market trend during the first quarter of 2023. As in the month of January, Doxycycline Hydrochloride prices inclined in China because of a substantial surge in both domestic and international demands. Ease in logistic charges and a continuous surge in demand further supported the positive price trend of Doxycycline Hydrochloride until the end of January. Following February, the prices went down again, with the settlement at USD 65320 /MT FOB Shanghai in China. Towards the termination of Q1-2023, the demand surged at a moderate rate which was balanced by the overall supplies among the market participants.
Europe
Throughout the first quarter of 2023, the market for Doxycycline Hydrochloride in Europe demonstrates a decremented trend in the European region, primarily in Germany. The price trend began on a positive note at the start of Q1 but gradually started to decline as February approached and ended Q1 on a bearish note. With this, the prices recorded for Doxycycline Hydrochloride during the month of February were settled at USD 72530/MT CFR Hamburg. Also, Market players focused on destocking their stockpiles for Doxycycline Hydrochloride API in order to prevent loss aversion. Furthermore, at the termination of Q1, the freight and shipping costs depreciated, which kept the market situation feeble.
For the Quarter Ending December 2022
North America
The Doxycycline Hydrochloride market showcased mixed sentiments during the fourth quarter of 2022 in the North American region. The Doxycycline Hydrochloride prices in the United States inclined till November and resumed their downward momentum in December. The reason behind an overall increase of 3.8% till November was surging demand from the downstream pharmaceutical and healthcare industries amidst high purchasing activities and limited inventories. By the termination of the fourth quarter, Doxycycline Hydrochloride prices declined by 4.1% owing to low offtakes for the product from regional buyers considering the weak demand. The CFR prices for Doxycycline Hydrochloride were assessed at USD 83550/MT in the United States at the end of the quarter.
Asia- Pacific
During the final quarter of 2022, the Doxycycline Hydrochloride market showcased an overall fluctuating pricing trend in the Asia-Pacific region. In the Chinese market, the prices dropped considerably with the onset of Q4 due to enough inventories with the local vendor amidst slow offtakes from downstream producers. However, the demand in mid-Q4 went on the higher side with lower stocks. Some production activities decreased owing to the lockdown in Shanghai with rising COVID cases, propelling the manufacturers to increase their rates to gain profits considering low inventories. Therefore, the Lopinavir API market dynamics got stable on the lower side over the end of Q4 in China, with FOB Shanghai prices settling at USD 66255/MT.
Europe
In Europe, the prices of Doxycycline Hydrochloride fluctuated during the Q4 of FY2022, resembling the North American market price trend. The primary reason for these fluctuations was the constant alteration of supply and demand dynamics. Additionally, fluctuations in trade frequency from China during the whole quarter also affected the market value of Doxycycline Hydrochloride. The slow offtake from downstream pharmaceuticals and healthcare industries was one of the factors behind this flutter price trend of Doxycycline Hydrochloride. Also, the inventories among domestic merchants hovered, which also influenced the mixed market sentiments of Doxycycline Hydrochloride in Europe. Thus, the CFR prices of Doxycycline Hydrochloride in Germany settled at USD 88860/MT in December.
For the Quarter Ending September 2022
North America
The third quarter of 2022 started positively for the North American Doxycycline Hydrochloride market, with prices settling at USD 85320/MT in July. Lack of inventory and high demand for the product from the downstream pharmaceutical industry were the reasons behind the spike. Many Chinese API production facilities were shut down for maintenance during the last week of July, significantly reducing imports into the US. However, these values eventually decreased from the second half of the quarter and were assembled at USD 83890/MT in September. Demand from the downstream sector declined during H2 as downstream entities were in a solid wait-and-see attitude, forcing US suppliers to cut their prices to increase orders.
Asia- Pacific
In the third quarter of 2022, the price trend for Doxycycline Hydrochloride in the Asia Pacific market exhibited a seesaw trajectory. The market opened with favorable sentiments in the first half of Q3, and prices eventually settled at USD 77376/MT in July. As some facilities underwent maintenance and others reduced their production because of the high temperatures, the market ran low on supplies. The producer did, however, experience a significant demand-supply imbalance in the market, which led to an increase in Doxycycline Hydrochloride prices in August. However, when plants started to resume production at the beginning of September due to a drop in temperature, the uptrend subsequently declined in September and was assembled at USD 71445/MT. Consequently, the market's supply returned to normal, and demand from the downstream pharmaceutical sector continued to be consistent.
Europe
The market fundamentals for Doxycycline Hydrochloride in Europe were comparable to those in North America in the Q3 of 2022. However, CFR prices tended to rise to USD 92810/MT in the first half of the quarter due to a shortage of product inventories in the German domestic market. Later in the second half, prices dropped, and by the end of September had reached USD 88070/MT. Domestic merchants were forced to cut their costs due to the product's sluggish demand from end-user pharmaceutical industries. However, China's reduced price quotes as a result of resuming manufacturing operations during the second half of the quarter were also the cause of the downward trend in Europe.
For the Quarter Ending June 2022
North America
In the North American region, Doxycycline Hydrochloride witnessed a negative market sentiment during the second quarter of 2022 due to ample supplies, and domestic buyers were relatively quiet this quarter. Despite the Shanghai shutdown and other Covid-related economic barriers in China, after seasonal adjustment in April, US imports from China surged to an all-time high, significantly affecting the US market of Doxycycline Hydrochloride. Suppliers were able to meet demand on the supply side because they had plenty of inventory on hand. Still, demand-wise, offtakes from the end-user pharmaceutical and nutraceutical industries held steady throughout the quarter. In the United States, the CFR prices of Doxycycline Hydrochloride dropped by 11.6% this quarter with values settled at USD 82040/MT.
Asia- Pacific
The market trend for Doxycycline Hydrochloride exhibited a negative path in the second quarter of 2022. Participants in the sector claimed that demand in the downstream pharmaceutical and nutraceutical sectors remained weaker than expected. China is the world's largest producer of Doxycycline Hydrochloride; its trade restriction has significantly impacted commerce with importing nations. It seems clear that the delays off the coast will take a bit longer to overcome, given the repeated predictions for bottleneck relief with little progress. Manufacturing and logistics are stifled by China's "ineffective" zero-tolerance rules and limitations. In China, the FOB Shanghai prices of Doxycycline Hydrochloride sharply declined by more than 25% this quarter with values settled at USD 60555/MT.
Europe
Doxycycline Hydrochloride prices in the European market have declined since April, supported by abundant inventories and shaky demand. In addition, Doxycycline Hydrochloride prices decreased with subdued market sentiment due to the reduced production cost of raw material Terramycin during the second quarter of 2022. Additionally, the market fundamentals have also been hindered by a decline in demand from the downstream pharmaceutical and nutraceutical sectors resulting in a plunge in prices in the German market. Furthermore, in terms of inventories, slowing demand impacted the market dynamics with rising stocks of Doxycycline Hydrochloride. In Germany, the CFR prices of Doxycycline Hydrochloride scaled down to 10.7% in this quarter with values settled at USD 86800/MT.
